Trial NCT00058461

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-01804
Secondary IDs: ANHL0121 CDR0000298751 COG-ANHL0121 NCI-2012-01804 U10CA098543

Last trial update was posted on 2013-10-08

MeSH Interventions

Carboplatin Cytarabine Etoposide Ifosfamide Methotrexate Rituximab

MeSH Conditions

Burkitt Lymphoma Leukemia Leukemia, Lymphoid Lymphoma Lymphoma, Large B-Cell, Diffuse Lymphoma, Large-Cell, Immunoblastic Lymphoma, Non-Hodgkin Plasmablastic Lymphoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Recurrence

Other Conditions

B-cell Childhood Acute Lymphoblastic Leukemia Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma L3 Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID